The DigitalHealth.London Leap programme features mentoring opportunities from a dedicated and diverse programme advisory panel consisting of subject matter experts in their respective fields.
Strategic Advisor – Health Innovation at Four Points Consulting Ltd
Venture Partner with Conduit Connect
Aahuti is an active leader in the digital health eco-system working at the intersection of innovators, investors, payors and providers of healthcare. Aahuti works with early-stage ventures helping them to figure out how to succeed and scale in their target markets. This includes commercial strategy development; creation of go-to-market plans testing them with market entry tactics; and a focus on approaches to create patient engagement and clinical adoption. Prior to her move into health-tech, Aahuti spent 20+ years delivering innovation strategies within well-respected organisations commissioned by their Boards and Executive Teams; this included multi-nationals across 13 industries as well as private and public healthcare providers.
Founder of BackCare Foundation
MSK Clinician at Royal London Hospital for Integrated Medicine
Anji brings together a background of growing and running a London-based SME, a role as an AHP in the NHS and a history of investment experience. After a degree in Econometrics, Anji began her career at Barclays, spending 10 years working as an Investment Director in SME equity funding. With experience assessing new opportunities, leading investments and sitting at board level, she has an understanding of fast growth companies.
Retraining as an osteopath, she has grown a six-figure business in the last 8 years, treating, training and teaching across Europe as an expert in BackCare. She has spent 7 years running an innovative clinic at UCLH for patients with chronic low back pain. Over the last 5 years, Anji has worked with other healthcare SMEs providing them with mentoring and coaching support. As a diverse founder based in London herself, she understands the challenges of growing a business in the healthcare industry and is keen to share her knowledge with the companies who are accepted on the programme.
Entrepreneur-in-residence at Francis Crick Institute
Barbara has worked on the commercial side of life sciences for thirty years, first in a large organisation (ICI/Zeneca/AstraZeneca), before transitioning to the entrepreneurial world of biotech. Barbara joined the Francis Crick Institute in January 2018 as an Entrepreneur-in-residence, where amongst other things, she co-founded, led and now is Chair of the KQ Labs accelerator, which is focused on start-ups from all over the UK that are making use of data/AI applied to health. She is also the Chief Business Officer of Autifony, where she is responsible for strategic partnering, fundraising and commercial aspects of drug development for CNS disorders.
Barbara was also Chair of Puridify, a UCL spin-out with a breakthrough biotherapeutics purification technology, which was acquired by GE (now Cytiva) in November 2017. She is a member of the investment committees of the LifeArc Early Ventures Fund, and the Cambridge Enterprise Seed Fund. Previously, Barbara was CEO of Stabilitech, and she was Commercial Director at Arrow Therapeutics until the company was acquired by AstraZeneca. Barbara was also Senior Business Development Manager at Celltech. Barbara has a BA and D Phil in Chemistry from the University of Oxford, and is a Sloan Fellow from London Business School.
Dr MaryAnn Ferreux
Executive Medical Director at Health Innovation Kent Surrey Sussex
Associate Non-Executive Director at Kent and Medway NHS Partnership Trust
MaryAnn works as the joint Medical Director for the Kent, Surrey and Sussex Academic Health Science Network and is an Associate Non-Executive Director for the Kent and Medway NHS Partnership Trust. She has international experience working across both the Australian and UK health systems, with specialist qualifications in health system leadership, management, and public health. She has held Board level roles as a medical leader in both primary and secondary care and is passionate about improving the patient experience and delivering better integrated care.
She is a Fellow of the Royal Australasian College of Medical Administrators, the Australasian College of Health Service Management, the UK Faculty of Clinical Informatics and the Faculty of Medical Leadership and Management, as well as being a Certified Health Executive and leadership coach. She has a special interest in researching health equity and the impact of the social determinants of health; her current doctoral studies will explore equity and health inequalities within the Kent and Medway regions.
She is leading several initiatives to promote diversity and inclusion in healthcare and is a Trustee and Chair of the Royal College of Physicians Edinburgh Equality, Diversity and Inclusivity Committee and Chair of the Royal Australasian College of Medical Administrators Diversity & Inclusion Committee. MaryAnn is committed to using her position to role-model an inclusive leadership approach whereby she supports, mentors and coaches clinicians from disadvantaged backgrounds to widen participation in medicine and increase diversity within healthcare leadership and management.
Dr Michael Watts
Co-founder and CEO of Blüm Health Ltd
On a mission to break down the barriers to innovation within the global digital health industry, Michael is an NHS doctor, NHS Innovation Accelerator Fellow and MBA Graduate by background. Over the last few years, he has been the Co-founder and Managing director of Blüm Health Ltd, an industry-disrupting digital health organisation that collaboratively works with NHS trusts, Universities and SMEs to design, build, and scale digital health software solutions, in the hope to empower solo entrepreneurs to turn their ideas into reality whilst also enabling large, rigid institutions to unlock their innovation potential. Alongside the Blüm Team, his focus is to build NHS-ready software and get it right the first time. This means building solutions that are regulatory compliant, patient-centric, and accessible from the outset, and this model has seen the successful implementation of seven solutions across the public and private sectors in just three years. Michael also supports SMEs planning to internationalise early, with Blüm being on the Department for Business and Trades ‘Go Global’ Showcase.
Dr Mridula Pore
Co-founder of Peppy
Mridula is Co-Founder of Peppy, an alumnus company of the DigitalHealth.London Accelerator. Peppy provides health support to employees going through life’s big transitions, such as becoming a parent or going through the menopause. Peppy brings together Mridula’s passion for affordable, accessible healthcare with her love of innovation. Before moving into digital health, she led NHS service redesign projects as a management consultant at McKinsey, and launched several high-profile generic pharmaceuticals as head of the UK retail pharmacy business at Sandoz, a Novartis company. Mridula was educated in India, the UK and the USA. She holds an MEng from Cambridge, a PhD from MIT and an MBA from MIT Sloan. She lives in West London with her husband and young children.
Investment Director at Calculus Capital
Board member of MIP Discovery and Laverock Therapeutics
Elizabeth joined Calculus Capital in 2022 and has over 20 years’ experience in Life Science investing. Elizabeth joined Calculus from Klein-Edmonds Associates, which she founded in 2015 to support and advise stakeholders in the UK’s Life Sciences industry. Her career spans equity research and investment analysis, and her client base included – amongst others – Radnor Capital Partners, Grant Thornton, and the Bio-Industry Association. She has a BSc in Applied Biology, an MA in History of Medicine, and an MBA. Elizabeth’s role is to source and execute new deals, as well as advising a number of Calculus’ portfolio companies.
Founder and CEO of Perci Health
Kelly is the Founder and CEO of Perci Health, a current DigitalHealth.London Accelerator company. She is a healthcare executive with 15 years of cancer care experience, a registered oncology dietitian and head of therapies within a large NHS cancer centre. Kelly has published academic research on the detection and management of sarcopenia to improve cancer treatment tolerance. She is also the COO of HCA International Cancer Network, managing 7 cancer centres across the UK. Kelly founded Perci Health, the UKs first virtual cancer survivorship clinic in 2020. She has raised over £5m to date to support the growth of the business and built a network of >80 cancer specialist healthcare professionals delivering care on the platform.
Consultant Cardiologist at West Middlesex University Hospital
Sadia is a Consultant Cardiologist with an interest in heart failure, atrial fibrillation, community cardiology and digital transformation and innovation. She is service lead for cardiology and has helped set up community heart failure services and improved care for heart failure patients. She has led nationally recognised work in atrial fibrillation care, with her work being adopted across London. Sadia has a keen interest in research and innovation and has been clinical lead in several studies. She also has a teaching role with Imperial College London, acting as a personal and academic tutor to a group of up to 25 undergraduates and supervising PhD, MD and MPH students.